India  
 
NewsR.in

Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: Study

IndiaTimes Thursday, 16 May 2024
Bharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable short-term safety profile as compared to those reported with mRNA vaccines but adolescent females and those with a history of allergy were at a 1.6 times and three times increased risk of AEFI after taking Covaxin.
0
shares		ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Bust Premiership trio owe £30m in unpaid Covid loans

 London Irish, Wasps and Worcester went out of business needing to repay more than £30m of Covid relief loans, a National Audit Office report says.
BBC Sport

Messenger RNA Messenger RNA RNA that is read by the ribosome to produce a protein

Russian Claims Big Cancer Breakthrough: New Anti-Cancer Vaccine To Shatter America in 2025 [Video]

Russian Claims Big Cancer Breakthrough: New Anti-Cancer Vaccine To Shatter America in 2025

In a groundbreaking development, Russia has announced a new anti-cancer vaccine that could revolutionize cancer treatment worldwide. Set to be released by early 2025, the vaccine, developed through a collaboration of top Russian research centers, promises to suppress tumor growth and prevent metastasis. With pre-clinical trials showing promising results, this mRNA-based vaccine is poised to make a major impact in the fight against cancer. Experts predict that it could shake up cancer treatment protocols in the U.S. and beyond, potentially saving millions of lives. #RussianCancerBreakthrough #AntiCancerVaccine #CancerVaccine2025 #CancerResearch #CancerCure #CancerTreatment #CancerInnovation #BreakthroughVaccine #CancerFighting #RussianScience #CancerRevolution #VaccineForCancer #FutureOfMedicine #CancerHope #MedicalBreakthrough ~HT.178~GR.124~PR.152~ED.103~

Credit: Oneindia    Duration: 03:02Published

Related news from verified sources

Shreyas suffered heart attack due to COVID vaccine?

 Actor Shreyas Talpade shared about his heart attack last year, questioning its possible link to the Covid vaccine. He seeks clarity on whether it's due to Covid...
IndiaTimes Also reported by •Mid-Day •Bollywood Life •DNA

TOI Health News Morning Briefing

 Here is the TOI health news morning briefing. Legal action against Serum Institute over Covid deaths. AstraZeneca admits side effects. India reports FLiRT COVID...
IndiaTimes

What is Covishield's rare side effect, TTS?

 Prominent vaccine manufacturer Astra Zeneca acknowledged in a court filing that TTS, a disorder that can result in blood clots and low platelet counts, can be...
IndiaTimes Also reported by •DNA